Showing 5121-5130 of 10638 results for "".
Sexual Function & Fertility in Men After Cancer
https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/sexual-function-and-fertility-men-after-cancer/7360/Given the multitude of concerns a male patient with cancer must deal with, sexual dysfunction and infertility are two such concerns that often gets bypassed by clinicians addressing more "priority" issues. What kinds of challenges do these patients deal with, and how can physicians better assess andEthical Issues in Genetic Testing: the Who, What, Where, How and Why of Sequencing Information
https://reachmd.com/programs/genetically-speaking/ethical-issues-genetic-testing-who-what-where-how-and-why-sequencing-information/7310/The advances of genetic and genomic medicine within clinical practice enable more precisioned, predictive care decisions. But with these new capabilities and access points to patient information come new ethical challenges. Understanding which information will be clinically valuable, how and where tIdentifying Unstable Coronary Plaques
https://reachmd.com/programs/heart-matters/identifying-unstable-coronary-plaques/6432/Acute coronary syndromes in patients who have undergone percutaneous coronary intervention is the subject of the conversation between guest Dr. Gary Mintz, chief medical officer of the Cardiovascular Research Foundation, an independent, academically focused nonprofit organization dedicated to improvDiabetic Retinopathy: Types, Causes, and Associated Somatic Changes
https://reachmd.com/programs/revealing-retina/diabetic-retinopathy-types-causes-and-associated-somatic-changes/5625/The eyes can yield clues to vascular issues elsewhere in the body. How can the two forms of diabetic retinopathy, which are non-proliferative and proliferative, affect vision, and how might retinopathy be associated with somatic effects resulting from diabetes? Dr. Alan Ruby, opthamologist and cliniIs the PA Profession Recession-Proof?
https://reachmd.com/programs/clinicians-roundtable/is-the-pa-profession-recession-proof/4409/Despite the current economic recession in the United States, the PA profession is growing at a rapid pace. Currently there are 73,000 PAs nationwide and 5000 new PAs are graduating every year. Cynthia Lord, president of the American Academy of Physician Assistants and the program director of the PhyAn Emerging Vaccine Helps Prevent Prostate Cancer
https://reachmd.com/programs/clinicians-roundtable/an-emerging-vaccine-helps-prevent-prostate-cancer/3628/Can a vaccination help prevent prostate cancer? Dr. James Gulley, director of the Clinical Trials Group of the Laboratory of Tumor Immunology and Biology at the National Institutes of Health discusses studies involving the use of cancer vaccines to modulate the immune response in cancer patients. TInvesting in Cures for Multiple Sclerosis
https://reachmd.com/programs/clinicians-roundtable/investing-in-cures-for-multiple-sclerosis/3602/Through a venture philanthropy called Fast Forward, LLC the National Multiple Sclerosis Society plans to deploy 1.5 to 2 million dollars in the next 18 months as seed funding to biotech companies on the path towards cures for Multiple Sclerosis. Our guest, Timothy Coetzee executive director of FastFinerenone vs Placebo in Type 1 Diabetes and CKD: Updates From the Phase 3 FINE-ONE Trial From the Kidney Meeting 2025 in Houston
https://reachmd.com/clinical-practice/nephrology/finerenone-vs-placebo-in-type-1-diabetes-and-ckd-updates-from-the-phase-3-fine-one-trial-from-the-kidney-meeting-2025-in-houston/36517/Are you current with the findings from the phase 3 FINE-ONE trial? Join Dr. Heerspink as he summarizes what you need to know about this study.Boosting Colorectal Cancer Re-Screening: The Role of Spanish Language Navigation
https://reachmd.com/programs/clinicians-roundtable/boosting-colorectal-cancer-re-screening-the-role-of-spanish-language-navigation/36539/A recent study showed that tailored Spanish-language navigation paired with the multi-target stool DNA (mt-sDNA) test can significantly improve colorectal cancer re-screening adherence among Spanish-speaking patients. Hear Ryan Quigley speak with Dr. Mallik Greene, a coauthor of the study, about howOperational Considerations for Bispecific T-Cell Engager Therapies
https://reachmd.com/programs/medical-industry-feature/operational-considerations-for-bispecific-t-cell-engager-therapies/33005/In recent years, bispecific T-cell engager therapies have emerged as an innovative approach for treating cancer by directing the patient’s own T-cells to target tumor‑associated antigens on cancer cells.1 However, the implementation of bispecific T-cell engager therapies into clinical practice come